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Congenital anomalies of the kidney and urinary tract (CAKUT) 
account for more than 50% of abdominal masses found in neonates 
and involve about 0.5% of all pregnancies. CAKUT has a major 
role in renal failure, and increasing evidence suggests that certain 
abnormalities predispose to the development of hypertension and 
cardiovascular disease in adulthood. To understand the pathogenesis 
of human renal anomalies, understanding the development of kidney 
is important. Diverse anomalies of the kidney corresponding to defects 
at a particular stage of development have been documented recently; 
however, more research is required to understand the molecular 
networks underlying kidney development, and such an investigation 
will provide a clue to the therapeutic intervention for CAKUT. 
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Introduction
Congenital anomalies of the kidney and urinary tract (CAKUT) 
account for more than 50% of the abdominal masses found in 
neonates and involve about 0.5% of all pregnancies
1). Despite recent 
advances in prenatal diagnosis and early surgical intervention, 
these diseases still remain the primary cause of kidney failure 
in infants and children. Registry data from across the world, 
regarding the primary renal disease-mediated development of end-
stage renal failure in children show that approximately 50% of 
the cases are due to CAKUT
2, 3), and increasing evidence suggests 
that these abnormalities predispose children to hypertension and 
cardiovascular disease during adulthood
4). 
A wide spectrum of diseases is encompassed by the term 
“CAKUT,” including kidney anomalies such as aplasia, hypoplasia, 
and multicystic dysplastic kidneys; ureteric anomalies such as 
megaureter, ureteropelvic junction obstruction, ureterovesical 
junction obstruction or incompetence, and duplex kidneys/ureters; 
and anomalies of the bladder and urethra
5), a group that reflects 
the common causes of these malformations. These anomalies have 
a familial pattern, involving incomplete and variable penetrance, 
often leading to the production of different anatomical patterns. 
Therefore, these assorted structural anomalies have been speculated 
to share a common pathogenic mechanism and genetic background 
6). Renal functional impairment may develop postnatally from 
bacterial pyelonephritis and/or persistent urinary flow impairment 
causing renal atrophy and fibrosis, but the primary “hit” in 
CAKUT is clearly a developmental one, resulting in renal dysplasia 
5). Recently, diverse developmental anomalies of the kidney 
corresponding to defects at a particular stage of development have 
been reported (Table 1). 
Normal development of the human kidney begins at the 
fifth week of gestation when the ureteric bud extends from the 
mesonephric duct into the metanephric blastema. Development 
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of the kidney requires complex interactions between epithelial 
cells in the ureteric bud and the surrounding mesenchymal cells; 
these interactions result in controlled cell proliferation, death, and 
differentiation. The ureteric bud branches serially and differentiates 
into the collecting ducts and ureter, with the distal end forming 
the bladder trigone. Meanwhile, a part of the mesenchyme 
undergoes epithelial conversion to form the nephron from the 
glomerulus to the distal tubules, with the remainder developing 
into the supporting renal interstitium
4, 7). Ureteric bud induction 
and differentiation is now known to depend on the interactions 
mediated by growth factors, matrix molecules, and transcriptional 
factors that control the expression of these genes
5).
Ureter induction
1. Renal agenesis
The most crucial event in kidney development is the first 
signaling process that induces the outgrowth of the ureter from the 
mesonephric duct. Central to the induction process is the expression 
of the signaling molecule glial cell line-derived neurotropic factor 
(GDNF), which is released from the mesenchyme and binds to its 
receptors, namely, receptor tyrosine kinase (RET) and GDNF-
family receptor α 1 (GFRA1), in the mesonephric duct
8, 9). After 
binding to its receptors RET and GFRA1, GDNF activates a 
signaling cascade that eventually leads to epithelial cell proliferation 
and epithelial branching
8, 10). Thus, the failure of GDNF-RET 
signaling is reported to be linked to renal agenesis. Renal defect 
in Gfrα 1 knockout mice has been reported
11), but mutations in 
GDNF or RET have not been found in human patients with 
kidney defects. This could be because human kidney development 
is not susceptible to slight reduction in protein level that results from 
heterozygous inactivation, and homozygous mutations can escape 
detection because of embryonic lethality
4). However, mutations 
in eyes-absent homologue 1 (EYA1), sine oculis homeobox 
homologue 1 (SIX1), and SIX5–the 3 regulators of GDNF–result 
in branchiootorenal syndrome
12). Outside of the metanephric 
mesenchyme, the signaling molecule bone morphogenetic protein 
4 (BMP4) inhibits GDNF activity, and the expression of gremlin 1 
(GREM1) leads to the inactivation of BMP4. Thus, mice carrying 
mutations in Grem 1 show renal agenesis due to Bmp4-mediated 
inhibition of Gdnf signaling
13), and mutations in BMP4 have been 
reported in human renal hypodysplasia patients
14).
2. Ureter malformation
Receptor tyrosine kinase antagonist sprouty 1 (SPRY1) acts 
downstream of GDNF by inhibiting intracellular RET signaling; 
mutations in this gene result in ectopic ureters by rendering the duct 
more sensitive to GDNF
15).
Forkhead box protein C1 (FOXC1), slit homologue 2 (SLIT2), 
and its receptor roundabout homologue 2 (ROBO2) have been 
reported to confine GDNF expression to the caudal part of the 
nephric cord in mice studies
16), and mutations in genes encoding 
these proteins lead to an expansion of GDNF expression to the 
rostral part, resulting in multiple ureters. Particularly, missense 
mutations of ROBO2 have been reported to be associated with 
vesicoureteral reflux (VUR)
17, 18). 
Primary VUR is a common disease, occurring with an inci-
dence of approximately one in 100 infants, and it accounts for 
a high familial occurrence with a prevalence of 27-50% among 
siblings and offspring of patients, indicating autosomal dominant 
inheritance with reduced penetrance
18). At present, VUR has been 
widely accepted as a genetically heterogeneous disorder
19, 20), and 
genes participating in ureter induction are under investigation. 
Ureteric bud branching
1. Renal hypoplasia
The ureteric bud branches serially, and nephrons are induced 
by a signal from the tip of the ureter. Because the kidney size is 
primarily determined by the total number of nephrons formed 
during the development, defect in the ureteric bud branching 
results in reduced nephron number and functional renal tissue. 
Recent studies have shown that there is a strong correlation between 
Table 1. The Syndrome and Genetic Mutations Associated with Renal 
Tract Malfomations
Congenital defects Syndromes Gene defects
Renal agenesis
Ectopic ureter
Multiple ureter
VUR
Renal hypoplasia
Glomerular defects
Tubular defects
Cystic kidneys
Renal dysplasia
Branchiootorenal
Renal coloboma
Townes Brocks
Nail-patella 
Denis-Drash
Congenital NS
Renal tubular dysgenesis
NPHP
ARPKD
ADPKD
Renal cyst and diabetes
Fraser
Kallman
EYA1, SIX1, SIX4, SIX5
SPRY1
FOXC1, SLIT2, ROBO2
ROBO2
WNT II
PAX2
SALL1
LMX1B
WT1
NPHS1, NPHS2
REN, AGT, ACE, AGTR1
NPHP2, NPHP1, NPHP4, 
NPHP3
PKHD1
PKD1, PKD2
TCF2/HNF1β
FRAS1
KAL1Korean J Pediatr 2010;53(7):729-734 • DOI: 10.3345/kjp.2010.53.7.729    731
the number of nephrons and the risk of primary hypertension, with 
the average hypertensive patients having 46% fewer glomeruli than 
those in normotensive individuals
21), supporting the hyperfiltration 
hypothesis
22). 
Growth of the ureter requires continuous inductive signals from 
the mesenchyme. WNT11, which is produced by the ureteric 
bud tips, seems to complete a feedback loop that acts on the 
mesenchyme to promote GDNF expression, and mutations that 
inactivate Wnt11 lead to the development of kidneys that are 36% 
smaller than those of the wild type
23). Similarly, a reduction in 
GDNF-RET signaling results in reduced amounts of WNT11, 
and removing one copy of WNT11 and RET further aggravates 
the hypoplastic kidney phenotype. 
GDNF-RET signaling is very crucial; mutations that affect the 
expression of transcriptional regulators of these genes also result in 
reduced ureter branching, and heterozygous mutations in paired-
box protein 2 (PAX2), which activates the expression of both 
GDNF and RET, cause renal coloboma syndrome in humans
24).
Patterning
The first glomeruli form at 8-9 weeks of gestation, and new 
nephrons are added at the outer layer of the cortex until 32-36 
weeks. On induction, nephron precursor cells condense to form a 
cap structure that surrounds the ureter. These cells then undergo a 
mesenchyme-to-epithelial transition to form the renal vesicle, which 
develops into a comma-shaped body and then an S-shaped body. 
The S-shaped body elongates and differentiates into the various 
segments of a nephron. Each nephron segment fulfils particular 
physiological functions, such as blood filtration, pH regulation, 
and reabsorption and secretion of solutes. Gene expression patterns 
are segment specific, and defects at this stage of development result 
in specific glomerular and tubular diseases, but knowledge on the 
genetic program that leads to nephron segmentation is limited.
Podocyte cells mature under the control of transcription 
factors such as Wilms’ tumor transcription factor (WT1). WT1 
in presumptive podocyte layer induces vascular growth through 
the activation of vascular endothelial growth factor (VEGF) 
that attracts endothelial cells, which in turn produce platelet-
derived growth factor (PDGF) that supports the differentiation of 
mesangial cells. Hence, WT1 mutation in humans is associated 
with diffuse mesangial sclerosis in Denys-Drash syndrome 
25). Terminal differentiation of the podocyte layer requires the 
regulation of LIM homeobox transcriptional factor 1β  (LMX1B), 
and lack of LMX1B interferes with the expression of podocyte-
specific genes, mutations in which cause nail-patella syndrome
26).
CAKUT phenotype
Recently, there have been enormous advances in the field 
of kidney development, and genes functioning at specific 
developmental stages have been identified. However, expression 
patterns are not always restricted to a single cell lineage, and 
phenotypes can vary greatly depending on the type of mutation in 
a particular gene. 
The critical role of rennin-angiotensin system (RAS) during 
kidney development is widely accepted, and mutations in the genes 
encoding components of the RAS or pharmacological inhibition 
of RAS results in diverse malformations of the kidney and urinary 
tract. Of the 2 receptors for angiotensin II, angiotensin type 2 
receptor has been recently recognized, and its gene AGTR2 is 
primarily an embryonic gene, which is actively transcribed from 
the onset and throughout the embryonic development of the 
kidney and urinary tract system
6). It has been reported that in 
Agtr2 mutant mice, a wide anatomical spectrum of anomalies 
are randomly noted in the same pedigree
27), with each specific 
anatomical pattern having its own counterpart in humans. WTI 
is required for ureter induction, formation of the nephron, and 
for differentiation and maintenance of the glomerulus. Hence, 
mice carrying Wt1 mutations lack kidneys, show renal dysplasia, 
or develop renal failure at adulthood
4). Point mutations that affect 
specific sites of the RET protein lead to a wide range of CAKUT 
phenotypes
28), probably because point mutations might specifically 
affect the interactions of the RET protein with other regulatory 
proteins, leading to the development of a diverse spectrum of 
phenotypes. Therefore, genotype-phenotype studies of CAKUT at 
a large scale will be required to provide a clue for the investigation of 
kidney development.
Cystic kidney disease
Cystic diseases of the kidney (CDK) are a group of distinctive 
kidney diseases, leading to the formation of dilated tubules or 
cysts. They are among the most frequent genetic lethal diseases 
in humans. Autosomal dominant forms of CDK, the most 
prominent example of which is autosomal dominant polycystic 
kidney disease (ADPKD), are characterized by end-stage renal 
disease (ESRD) in adulthood. Autosomal recessive form of CDK, 
such as nephronophthisis (NPHP) and autosomal recessive 
polycystic kidney disease (ARPKD), cause ESRD in childhood or 
adolescence. 
By positional cloning, the first 2 genes that have been implicated 
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which encode the proteins polycystin1 and 2, respectively–have 
been identified
29, 30). The 2 proteins have a role in the maintenance 
of renal tubular cell differentiation. ARPKD is characterized by 
bilateral renal cystic enlargement; most patients develop ESRD 
in infancy, early childhood, or adolescence. By using positional 
cloning, researchers identified polycystic kidney and hepatic disease 
1 (PKHD1), which encodes a novel protein fibrocystin/polyductin 
that has a role in terminal differentiation of the collecting duct and 
biliary systems
31). NPHP is an autosomal recessive cystic kidney 
disease and the most frequent genetic cause for ESRD in the first 
3 decades of life. Unlike PKD, cysts in ESRD are mostly restricted 
to the corticomedullary border of the kidneys, and kidney sizes 
are reduced or normal. In all, 5 NPHP-associated genes, NPHP1-
NPHP5, have been identified by positional cloning; these genes 
encode nephrocystin proteins, nephrocystin 1-nephrocystin 5, 
respectively. These proteins are involved in cell-cell and cell-matrix 
adhesion signaling events and in cell division
32). Nevertheless, the 
molecular link between these functions and the development of 
renal cysts remains elusive.
Despite their clinical and pathological heterogeneity, the similar 
outcome of cyst formation has led to the assumption that gene 
defects in each of these disorders may disrupt a common pathway. 
Recent studies revealed that cystoproteins, the products of cystic 
kidney disease genes, are expressed in the sensory organelles known 
as primary cilia, in the basal bodies or centrosomes
33). Primary cilia 
link mechanosensory, visual, osmotic, gustatory, and other stimuli 
to the mechanisms of cell-cycle control and epithelial cell polarity. 
The link between the cilium and centriole suggests a mechanism 
underlying cilial sensing required to maintain the growth-arrested 
phenotype of mature tubules
34).
The pathogenic link between cystoprotein expression in the cilia 
and the renal cystic phenotype remains unknown, and one of the 
CDK variants medullary cystic kidney disease 2 (MCDK2) is 
caused by mutations in uromodulin (UMOD); the expression of 
this gene has not been thus far found in the cilia, basal bodies, or 
centrosomes
33). Nevertheless, this “ciliopathy” model for explaining 
the mechanisms underlying various cystic diseases in the unifying 
theory is an attractive hypothesis.
Renal dysplasia
Dysplastic kidneys are abnormally developed kidneys with 
poorly branched/differentiated nephrons and collecting ducts, 
increased stroma and occasional cysts, and metaplastic tissues, 
such as cartilage
5). Although many dysplastic kidneys develop 
by chance, some underlying causes, including genetic defects, 
lower urinary tract obstruction, and teratogen/drugs, might also 
exist
7). These conditions are not mutually exclusive and may 
occur simultaneously. Multicystic dysplastic kidneys (MCDK) 
are classically associated with non-patent ureters and obstruction, 
perhaps reflecting improper ureteric canalization
35). Animal 
studies in fetal sheep and mice suggest that postnatal urinary 
tract obstruction mimic human dysplastic kidneys, but the size of 
the cysts is never as large as that in MCDK, metaplastic cartilage 
does not form, and there is marked inflammation in the postnatal 
models, suggesting that other factors besides flow impairment are 
implicated in MCDK
7, 36), and that not all human dysplasia are 
associated with obstruction. Serial ultrasonography examinations 
before and after birth indicate that MCDK can enlarge and involute 
into an “aplastic” phenotype
37). Involution may represent an 
imbalance of programmed cell death and growth by proliferation 
because apoptosis in human dysplasia is prominent, especially in 
the stroma around the dysplastic tubules
38). Recent studies showed 
that disordered expression of diverse growth factors, cell survival 
genes, and transcription factor genes correlate with disordered cell 
turnover and maturation, resulting in excessive growth followed 
by apoptotic involution. Thus, renal dysplasia is considered as a 
dynamic disorder associated with abnormal kidney development. 
Upregulated proliferation occurs in human dysplastic epithelia, 
which may be critical for cyst formation, whereas there is excess 
apoptosis in the adjacent mesenchyme, which may be responsible 
for the adequate involution of dysplastic kidneys. These aberrant 
patterns of proliferation and cell death may partially be explained 
by abnormal expression of key nephrogenic molecules such as 
the transcription factor hepatocyte nuclear factor-1β  (HNF-1β ) 
and other growth factors, survival molecules, or adhesion/matrix-
associated proteins. 
HNF-1β , first identified as a liver-specific transcription factor, is 
also highly expressed in other epithelial organs, including kidneys 
and pancreas; in the kidney, HNF-1β  is restricted to the epithelial 
cells comprising renal tubules and collecting ducts
39). Mutations 
in the genes encoding HNF-1β  produce an autosomal dominant 
disorder maturity-onset diabetes of the young, type 5 (MODY5), 
also known as renal cysts and diabetes (RCAD), because affected 
individuals present with severe cystic kidney disease
40). Recently, 
mutations in HNF-1β  have been identified in children with 
sporadic renal hypoplasia/dysplasia and are known to be a frequent 
cause of bilateral hyperechogenic kidneys detected by prenatal 
ultrasonography
41). 
Besides HNF-1β , many individual components of dysplastic 
kidney have been reported, such as PAX2
42) and uroplakins
43), but 
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mutations in several renal developmental genes. Therefore, 
interactions between different factors need to be identified, 
and probably dynamic models of gene networks will have to be 
considered to understand these complex developmental processes.
Conclusion
In recent years, there have been enormous advances in our 
knowledge regarding human kidney development; however, 
more research is required to understand the molecular networks 
underlying kidney development. From an epithelial bud and a loose 
aggregate of mesodermal cells to a completely functional kidney, 
a fine tuning of network is needed, and the investigation of this 
networking will provide a clue to the therapeutic intervention for 
CAKUT. 
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